Yahoo Web Search

Search results

    • Two Is Better Than One in the Alzheimer’s Market

      Two Is Better Than One in the Alzheimer’s Market

      The Wall Street Journal via Yahoo Finance· 6 days ago

      Their Alzheimer’s drug, Leqembi, was approved by the Food and Drug Administration last year but it has failed...of drugs that target amyloid plaques in...